Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Adamas Pharmaceuticals Inc (ADMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A ARMISTICE CAPITAL, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2022 SC 13G/A Opaleye Management Inc. reports a 0% stake in Adamas Pharmaceuticals, Inc.
12/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/06/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/24/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/24/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/24/2021 8-K Resignation/termination of a director
Docs: "TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAMAS PHARMACEUTICALS, INC.",
"AMENDED & RESTATED BYLAWS OF ADAMAS PHARMACEUTICALS, INC."
11/24/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/23/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/23/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/18/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/10/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/01/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/25/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/25/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/25/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/20/2021 SC 13G/A HIRSCHMAN ORIN reports a 12% stake in Adamas Pharmaceuticals, Inc.
10/19/2021 SC 13D Magnetar Financial LLC reports a 6.8% stake in ADAMAS PHARMACEUTICALS, INC.
10/14/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/13/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/12/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/12/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy